| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-07 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-06 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-06 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
1e-05 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |